🦊/Lists

Biotech Investors & VC Firms in Asia-Pacific

571 firms in this list, with a median first check of $650K. 110 of them lead rounds. Generated from verified public data and updated continuously.

Shanghai Healthcare Capital
ShanghaiSeed–Series B
C-CAMP
BengaluruPre-Seed–Seed
CAS Star
Xi’anPre-Seed–Growth
IP Group
Pre-Seed–Seed
SDIC Venture Capital / SDIC Fund Management
BeijingSeed–Growth
Yamauchi No.10 Family Office
TokyoSeed–Growth
Zero2IPO
BeijingSeed–Late Stage
Zhangjiang Hi-Tech incubation ecosystem
ShanghaiPre-Seed–Growth
Y Combinator
San FranciscoPre-Seed–Series A$500K
21 people
New Enterprise Associates (NEA)
Menlo ParkSeed–Late Stage$200K – $40M
73 people
Bessemer Venture Partners
Redwood CitySeed–Late Stage$5M – $100M
61 people
Sequoia Capital
Menlo ParkPre-Seed–Late Stage$4.4M – $214M
47 people
Khosla Ventures
Menlo ParkPre-Seed–Late Stage$5K – $50M
51 people
General Catalyst
San FranciscoPre-Seed–Late Stage$30M
33 people
F-Prime Capital
CambridgePre-Seed–Late Stage$3M – $10M
110 people
OrbiMed
New YorkPre-Seed–Late Stage$1M – $75M
131 people
Norwest Venture Partners
Menlo ParkSeed–Late Stage$10M – $30M
35 people
Alumni Ventures
ManchesterPre-Seed–Late Stage$100K – $10M
33 people
Bain Capital Venture
BostonPre-Seed–Late Stage
162 people
Creative Destruction Lab (CDL)
TorontoPre-Seed–Series A$50K – $250K
37 people
Frazier Life Sciences
Palo AltoSeed–Late Stage
77 people
B Capital Group
Manhattan BeachPre-Seed–Late Stage$10M – $50M
36 people
Paladin Capital Group
WashingtonSeed–Late Stage$100K – $5M
75 people
In-Q-Tel
TysonsSeed–Growth$100K – $2.5M
15 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.